Resources

We examined how age-related patterns of cocaine and methamphetamine use vary by sexual identity and gender among a national sample.

This study identified patient clinical and sociodemographic characteristics, and, more originally, service use patterns as predictors of death from physical illness or accidental/intentional causes

This review aimed to assess the application and effectiveness of digital interventions to treat opioid use disorder globally.

Racial/ethnic minoritized patients are less likely to receive OAT compared to non-Hispanic White patients.

To understand patient experience of federal regulatory changes governing methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic.

The objective of this analysis was to measure rates of follow-up and use of medications for OUD (MOUD) after residential treatment among Medicaid enrollees in 10 states, and to understand the enrol

Health Canada conditionally approves new drugs using its Notice of Compliance with conditions (NOC/c) policy.

Racial/ethnic minorities have experienced disproportionate opioid-related overdose death rates in recent years.

Buprenorphine is an effective medication for the treatment of opioid use disorder (OUD), but the association between prior authorization policies and quality of care for individuals receiving bupre

To estimate the association between buprenorphine treatment gaps, opioid overdose, and health care spending.

The objectives of this study were to assess the prevalence and correlates of naloxone administration by police, as well as to examine overdose events where arrests were made and those in which the

We examined the impact of U.S. state opioid-prescribing policies on opioid overdose mortality following implementation.

We sought to examine the relationship between OAT engagement and crystal methamphetamine use and to assess if this relationship differs according to the ongoing use of unregulated opioids.